Abstract
Clonidine, an α‐adrenoceptor agonist, reduces human plasma melatonin levels when administered intravenously at 2–3 (μg kg−1 to sleeping volunteers. Measurement of plasma melatonin levels after administration of clonidine could be the basis for a clinical in‐vivo test of α‐adrenoceptors.
Original language | English (US) |
---|---|
Pages (from-to) | 555-556 |
Number of pages | 2 |
Journal | Journal of Pharmacy and Pharmacology |
Volume | 38 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1986 |
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science